Nutex Enterprise Value Over E B I T D A from 2010 to 2025
| NUTX Stock | USD 141.10 7.04 4.75% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 3.08326145 | Current Value 3.24 | Quarterly Volatility 14.6 K |
Check Nutex Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nutex Health's main balance sheet or income statement drivers, such as Selling General Administrative of 29.8 M, Total Revenue of 503.9 M or Gross Profit of 206.1 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.0418 or PTB Ratio of 1.16. Nutex financial statements analysis is a perfect complement when working with Nutex Health Valuation or Volatility modules.
Nutex | Enterprise Value Over E B I T D A | Build AI portfolio with Nutex Stock |
Latest Nutex Health's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Nutex Health over the last few years. It is Nutex Health's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nutex Health's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Nutex Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (12,766) | |
| Coefficient Of Variation | (114.40) | |
| Mean Deviation | 11,944 | |
| Median | (5,056) | |
| Standard Deviation | 14,604 | |
| Sample Variance | 213.3M | |
| Range | 51.5K | |
| R-Value | 0.48 | |
| Mean Square Error | 175.1M | |
| R-Squared | 0.23 | |
| Significance | 0.06 | |
| Slope | 1,483 | |
| Total Sum of Squares | 3.2B |
Nutex Enterprise Value Over E B I T D A History
About Nutex Health Financial Statements
Nutex Health investors use historical fundamental indicators, such as Nutex Health's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nutex Health. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 3.08 | 3.24 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nutex Stock Analysis
When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.